Tirofiban

Modify Date: 2024-01-03 12:19:35

Tirofiban Structure
Tirofiban structure
Common Name Tirofiban
CAS Number 144494-65-5 Molecular Weight 440.597
Density 1.2±0.1 g/cm3 Boiling Point 611.7±65.0 °C at 760 mmHg
Molecular Formula C22H36N2O5S Melting Point 223-225ºC
MSDS N/A Flash Point 323.7±34.3 °C

 Use of Tirofiban


Tirofiban(L700462;MK383) is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonistTarget: integrin IIb/IIIa Tirofiban hydrochloride monohydrate blocks platelet aggregation and thrombus formation. Tirofiban is an antithrombotic used in the treatment of unstable angina.Tirofiban, in a concentration-dependent manner reduced platelet aggregation evoked by ADP (IC50 approximately 70 ng/ml), collagen (IC50 approximately 200 ng/ml), and thrombin (IC50 approximately 5,000 ng/ml).

 Names

Name tirofiban
Synonym More Synonyms

 Tirofiban Biological Activity

Description Tirofiban(L700462;MK383) is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonistTarget: integrin IIb/IIIa Tirofiban hydrochloride monohydrate blocks platelet aggregation and thrombus formation. Tirofiban is an antithrombotic used in the treatment of unstable angina.Tirofiban, in a concentration-dependent manner reduced platelet aggregation evoked by ADP (IC50 approximately 70 ng/ml), collagen (IC50 approximately 200 ng/ml), and thrombin (IC50 approximately 5,000 ng/ml).
Related Catalog
References

[1]. Winter JP, Juergens CP. The role of tirofiban in the management of coronary artery disease. Cardiovasc Hematol Disord Drug Targets. 2008 Jun;8(2):138-46.

[2]. van 't Hof AW, Valgimigli M. Defining the role of platelet glycoprotein receptor inhibitors in STEMI: focus on tirofiban. Drugs. 2009;69(1):85-100.

[3]. Valgimigli M, Biondi-Zoccai G, Tebaldi M et al. Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. Eur Heart J. 2010 Jan;31(1):35-49.

[4]. Valgimigli M, Tebaldi M. Safety evaluation of tirofiban. Expert Opin Drug Saf. 2010 Sep;9(5):801-19.

[5]. Diaz JF, Cardenal R, Gomez-Manchero A, Sanchez-Gonzalez C. Safety and efficacy of tirofiban as adjunctive therapy for patients with ST-elevation myocardial infarction: a comparison versus placebo and abciximab. Cardiovasc Hematol Agents Med Chem. 2011 Jul 1;9(3):147-53.

 Chemical & Physical Properties

Density 1.2±0.1 g/cm3
Boiling Point 611.7±65.0 °C at 760 mmHg
Melting Point 223-225ºC
Molecular Formula C22H36N2O5S
Molecular Weight 440.597
Flash Point 323.7±34.3 °C
Exact Mass 440.234497
PSA 113.11000
LogP 4.14
Vapour Pressure 0.0±1.8 mmHg at 25°C
Index of Refraction 1.532
Storage condition -20°C

 Safety Information

Hazard Codes Xi
Risk Phrases 36/37/38
Safety Phrases S22-S26-S30-S36/37/39-S45
RIDADR UN3261
Packaging Group II
Hazard Class 8
HS Code 2942000000

 Precursor & DownStream

Precursor  2

DownStream  0

 Customs

HS Code 2942000000

 Synonyms

Tirofiban [BAN:INN]
N-(Butylsulfonyl)-O-[4-(piperidin-4-yl)butyl]-L-tyrosine
N-(n-butanesulfonyl)-O-(4-(4-piperidinyl)butyl)-(S)-tyrosine
MFCD05237246
2-S-(n-Butylsulfonylamino)-3[4-(piperidin-4-yl)butyloxyphenyl]propionic acid
(S)-2-(butane-1-sulfonylamino)-3-[4-(4-piperidin-4-yl-butoxy)phenyl]-propionic acid
Agrastat
Agrastat (TN)
N-(Butylsulfonyl)-O-[4-(4-piperidinyl)butyl]tyrosine
(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid
UNII-GGX234SI5H
Aggrastat
Tirofiban
Tirofiban (INN)
Tyrosine, N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-
(2S)-2-(butane-1-sulfonamido)-3-{4-[4-(piperidin-4-yl)butoxy]phenyl}propanoic acid
N-(BUTYLSULFONYL)-O-[4-(4-PIPERIDINYL)BUTYL]-L-TYROSINE
L-tyrosine, N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-
L700462
MK383
Top Suppliers:I want be here


Get all suppliers and price by the below link:

Tirofiban suppliers


Price: $161/5mg

Reference only. check more Tirofiban price